Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,336.00
(
0.43%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
93.48
(
-3.62%
)
Bitcoin
75,646.03
(
-0.26%
)
News Focus
News Focus
Post# of 518830
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

nidan7500

Send PM Follow Ignore
Followers 57
Posts 10479
Boards Moderated 0
Alias Born 09/21/2016

nidan7500

Re: Amatuer17 post# 302910

Saturday, 03/13/2021 11:16:09 AM

Saturday, March 13, 2021 11:16:09 AM

Post# of 518830

Further, prespecified exploratory analyses showed donanemab slowed the accumulation of tau across key brain regions in patients affected by Alzheimer's disease.



Wrong MOA, end of discussion. Even the leaders can be wrong. Stand in the door, get ready to jump while you are still in the air...IMO.

https://finance.yahoo.com/news/lillys-donanemab-slowed-alzheimers-disease-113000850.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News